glp-1 employer coverage news october 2025 Employers Take a Variety of Approaches to GLP-1 trends 2025: real-world data,

Obesity Science & Innovation Sep 24, 2026 TO Sep 25, 2025 | Boston, MA The Obesity Science & Innovation event drives the future of obesity therapeutics by bringing together the most innovative companies with the right partners

Developing a physical dependence on benzodiazepines complicates opioid issues and is likely to land patients in the hospital

Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study

All decisions described here are made in line with the Patient Group Directions (PGDs) under which DoseDirect operates